Nantahala Capital Management - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$1,690,000
-53.6%
5,113,958
+1.1%
0.05%
-52.7%
Q2 2020$3,643,000
+121.5%
5,060,1600.0%0.11%
+77.4%
Q1 2020$1,645,000
-53.1%
5,060,160
+1.2%
0.06%
-42.6%
Q4 2019$3,510,000
+5.6%
5,000,0000.0%0.11%
-12.2%
Q3 2019$3,323,0005,000,0000.12%
Other shareholders

There were no reported owners of HTG MOLECULAR DIAGNOSTICS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders